Abstract
Although several studies have been published on the gut microbiota composition, they are mainly focused on bacteria. Therefore, the world of gut yeasts, the “gut mycome”, is still unclear. Over the last years, brand new gut microbiota analysis techniques have been applied to the study of yeasts, with exciting results both in health and in disease. A therapeutic potential for many gastrointestinal and extra-intestinal diseases has been recognized for selected yeast strains, such as Saccharomyces boulardii. This narrative review represents an overview of the new evidences regarding the “gut mycome”.
Keywords: Gut mycome, gut microbiota, Saccharomyces boulardii, yeasts.
Current Pharmaceutical Design
Title:Role of Yeasts in Healthy and Impaired Gut Microbiota: The Gut Mycome
Volume: 20 Issue: 28
Author(s): Gianluca Ianiro, Giovanni Bruno, Loris Lopetuso, Francesca Bartoli Beghella, Lucrezia Laterza, Francesca D'Aversa, Giovanni Gigante, Giovanni Cammarota and Antonio Gasbarrini
Affiliation:
Keywords: Gut mycome, gut microbiota, Saccharomyces boulardii, yeasts.
Abstract: Although several studies have been published on the gut microbiota composition, they are mainly focused on bacteria. Therefore, the world of gut yeasts, the “gut mycome”, is still unclear. Over the last years, brand new gut microbiota analysis techniques have been applied to the study of yeasts, with exciting results both in health and in disease. A therapeutic potential for many gastrointestinal and extra-intestinal diseases has been recognized for selected yeast strains, such as Saccharomyces boulardii. This narrative review represents an overview of the new evidences regarding the “gut mycome”.
Export Options
About this article
Cite this article as:
Ianiro Gianluca, Bruno Giovanni, Lopetuso Loris, Beghella Bartoli Francesca, Laterza Lucrezia, D'Aversa Francesca, Gigante Giovanni, Cammarota Giovanni and Gasbarrini Antonio, Role of Yeasts in Healthy and Impaired Gut Microbiota: The Gut Mycome, Current Pharmaceutical Design 2014; 20 (28) . https://dx.doi.org/10.2174/13816128113196660723
DOI https://dx.doi.org/10.2174/13816128113196660723 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Serum IL-33 Level and IL-33, IL1RL1 Gene Polymorphisms in Asthma and Multiple Sclerosis Patients
Current Molecular Medicine An Overview on Phytochemical and Pharmacological Aspects of Echium amoenum
The Natural Products Journal Pharmaceutical Applications of the Benzylisoquinoline Alkaloids from Argemone mexicana L.
Current Topics in Medicinal Chemistry Recent Advances in the Design and Development of Anticancer Molecules based on PROTAC Technology
Current Medicinal Chemistry Fibrate-Associated Adverse Effects Beyond Muscle and Liver Toxicity
Current Pharmaceutical Design Flavonoids Isolated from Rumex aquaticus Exhibit Neuroprotective and Neurorestorative Properties by Enhancing Neurite Outgrowth and Synaptophysin
CNS & Neurological Disorders - Drug Targets New Prospective for Redox Modulation Mediated by Organo selenium and Organotellurium Compounds
Current Organic Chemistry Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Synthesis of Novel 4-Aryl-1,2,3,4-tetrahydroisoquinolines as Probes for Dopamine Receptor Ligands
Medicinal Chemistry The Other Side of Opioid Receptor Signalling: Regulation by Protein-Protein Interaction
Current Drug Targets ACKNOWLEDGEMENTS TO THE REVIEWERS
CNS & Neurological Disorders - Drug Targets In Silico Approaches Towards the Understanding of the Structure- Function Relationships in Metabotropic Glutamate Receptors (mGluRs) and other Family C GPRCs
Current Pharmaceutical Design Exosomal miR-214-5p Released from Glioblastoma Cells Modulates Inflammatory Response of Microglia after Lipopolysaccharide Stimulation through Targeting CXCR5
CNS & Neurological Disorders - Drug Targets Pharmacological Characterization of Ligands at Recombinant NMDA Receptor Subtypes by Electrophysiological Recordings and Intracellular Calcium Measurements
Combinatorial Chemistry & High Throughput Screening Lymphocytes in Alzheimer’s Disease Pathology: Altered Signaling Pathways
Current Alzheimer Research Current Status and Future Directions of Nanoparticulate Strategy for Cancer Immunotherapy
Current Drug Metabolism Astrocytes Exert and Control Immune Responses in the Brain
Current Immunology Reviews (Discontinued) The Role of Amyloid-Beta Derived Diffusible Ligands (ADDLs) in Alzheimers Disease
Current Topics in Medicinal Chemistry Strategic Aspects of NPY-Based Monoclonal Antibodies for Diagnosis and Treatment of Breast Cancer
Current Protein & Peptide Science Pathophysiology of Post-Operative Low Cardiac Output Syndrome
Current Vascular Pharmacology